Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2007 Sep 10;31(1):6–10. doi: 10.1002/clc.20040

Amiodarone for Atrial Fibrillation Following Cardiac Surgery: Development of Clinical Practice Guidelines at a University Hospital

Ujjaini Khanderia 1,✉, Deborah Wagner 2, Paul C Walker 2, Brian Woodcock 2, Richard Prager 3
PMCID: PMC6653377  PMID: 17847039

Abstract

Atrial fibrillation (AF) usually develops within the first 72 h following cardiac surgery, and is often self‐limiting. Within 48 h of acute onset of symptoms, approximately 50% of patients spontaneously convert to normal sinus rhythm. Thus, the relative risks and benefits of therapy must be carefully considered. The etiology of AF following cardiac surgery is similar to that in non‐surgical patients except that pericardial inflammation and increased adrenergic tone play an increasingly important role. Further, AF after surgery may be associated with transient risk factors that resolve as the patient moves out from surgery, and the condition is less likely to recur compared to AF arising in other circumstances. Immediate heart rate control is important in preventing ischemia, tachycardia‐induced cardiomyopathy, and left ventricular dilatation.

At our institution, amiodarone is frequently used as a first‐line drug for treating AF after cardiac surgery. Inconsistent prescribing practices, variable dosage regimens, and a lack of consensus regarding the appropriate use of amiodarone prompted the need for developing practice guidelines. Multidisciplinary collaboration between the departments of cardiac surgery, pharmacy, and anesthesiology led to the development of a protocol for postoperative AF. We review the clinical evidence from published trials and discuss our guidelines, defining amiodarone use for AF in the cardiac surgery setting. Copyright © 2007 Wiley Periodicals, Inc.

Keywords: amiodarone, atrial fibrillation, rhythm, rate, cardiac surgery

Full Text

The Full Text of this article is available as a PDF (242.5 KB).

References

  • 1. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, et al.: Amulticenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291: 1720–1729. [DOI] [PubMed] [Google Scholar]
  • 2. Villareal RP, Hariharan R, Liu BC, Kar B, Lee VV, et al.: Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol 2004; 43: 742–748. [DOI] [PubMed] [Google Scholar]
  • 3. Levy D, Kannel WB: Postoperative atrial fibrillation and mortality: Do the risks merit changes in clinical practice? J Am Coll Cardiol 2004; 43: 749–751. [DOI] [PubMed] [Google Scholar]
  • 4. Tamis JE, Steinberg JS: Atrial fibrillation independently prolongs hospital stay after coronary artery bypass surgery. Clin Cardiol 2000; 23: 155–159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Vorperian VR, Havighurst TC, Miller S, January CT: Adverse effects of low dose amiodarone: a meta‐analysis. J Am Coll Cardiol 1997; 30: 791–798. [DOI] [PubMed] [Google Scholar]
  • 6. Daoud EG, Strickberger SA, Man KC, Goyal R, Deeb GM, et al.: Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997; 337(25): 1785–1791. [DOI] [PubMed] [Google Scholar]
  • 7. Mitchell LB, Exner DV, Wyse DG, Conolly CJ, Prystai GD, et al.: Prophylactic oral amiodarone for the prevention of arrythmias that begin early after revascularization, valve replacement, or repair. PAPABEAR: a randomized controlled trial. JAMA 2005; 294: 3093–3100. [DOI] [PubMed] [Google Scholar]
  • 8. Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S: Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta‐analysis. Circulation 2002; 106: 75–80. [DOI] [PubMed] [Google Scholar]
  • 9. Di Biasi P, Scrofani R, Paje A, Cappiello E, Magnini A, et al.: Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation. Eur J Cardiothorac Surg 1995; 9: 587–591. [DOI] [PubMed] [Google Scholar]
  • 10. Larbuisson R, Venneman I, Stiels B: The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery. J Cardiothorac Vasc Anesth 1996; 10: 229–234. [DOI] [PubMed] [Google Scholar]
  • 11. Ferguson TB, Coombs LP, Peterson ED: Preoperative beta‐blocker use and mortality and morbidity following CABG surgery in North America. JAMA 2002; 287: 2221–2227. [DOI] [PubMed] [Google Scholar]
  • 12. Ali IM, Sanalla AA, Clark V: Beta‐blocker effects on postoperative atrial fibrillation. Eur J Cardiothorac Surg 1997; 11: 1154–1157. [DOI] [PubMed] [Google Scholar]
  • 13. Martinez EA, Epstein AE, Bass EB: Pharmacologic control of ventricular rate: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery. Chest 2005; 128: 56S–60S. [DOI] [PubMed] [Google Scholar]
  • 14. Mooss AN, Wurdeman RL, Mohiuddin SM, Reyes AP, Sugimoto JT, et al.: Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery. Am Heart J 2000; 140: 176–180. [DOI] [PubMed] [Google Scholar]
  • 15. Connolly SJ, Cybulsky I, Lamy A, Roberts RS, O'brien B, et al.: Double‐blind, placebo‐controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the Beta‐Blocker Length Of Stay (BLOS) study. Am Heart J 2003; 145: 226–232. [DOI] [PubMed] [Google Scholar]
  • 16. Salerno DM, Dias VC, Kleiger RE, Tschida VH, Sung RJ, et al.: Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. Am J Cardiol 1989; 63: 1046–1051. [DOI] [PubMed] [Google Scholar]
  • 17. Babin‐Ebell J, Keith PR, Elert O: Efficacy and safety of low‐dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. Eur J Cardiothorac Surg 1996; 10: 412–416. [DOI] [PubMed] [Google Scholar]
  • 18. Hohnloser SH, Kuck KH, Lilienthal J: Rhythm or rate control in atrial fibrillation. Pharmacological intervention in atrial fibrillation (PIAF): a randomized trial. Lancet 2000; 356: 1789–1794. [DOI] [PubMed] [Google Scholar]
  • 19. AFFIRM Investigators . A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825–1833. [DOI] [PubMed] [Google Scholar]
  • 20. Testa L, Biondi‐Zoccai GG, Dello Russo A, Belloci F, Andreotti F, et al.: Rate control vs. rhythm‐control in patients with atrial fibrillation: a meta‐analysis. Eur Heart J 2005; 26: 2000–2006. [DOI] [PubMed] [Google Scholar]
  • 21. Bradley D, Creswell LL, Hogue CW, Epstein AE, Prytowsky EN, et al.: Pharmacologic prophylaxis: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery. Chest 2005; 128: 39S–47S. [DOI] [PubMed] [Google Scholar]
  • 22. Martinez EA, Bass EB, Zimetbaum P: Pharmacologic control of rhythm: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery. Chest 2005; 128: 48S–55S. [DOI] [PubMed] [Google Scholar]
  • 23. Naccarelli GV, Jalal S: Intravenous amiodarone: another option in the acute management of sustained ventricular tachyarrythmias. Circulation 1995; 92: 3145–3155. [DOI] [PubMed] [Google Scholar]
  • 24. Deedwania PC: Department of veterans affairs CHF‐STAT investigators: spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Circulation 1998; 98: 2574–2579. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES